Proteomic analysis of PBMCs: characterization of potential HIV-associated proteins.

PubWeight™: 0.84‹?›

🔗 View Article (PMC 2850332)

Published in Proteome Sci on March 12, 2010

Authors

Lijun Zhang1, Xiaofang Jia1, Xiaojun Zhang2, Jianjun Sun1, Xia Peng1, Tangkai Qi1, Fang Ma1, Lin Yin1, Yamin Yao1, Chao Qiu3, Hongzhou Lu1

Author Affiliations

1: Shanghai Public Health Clinical Center affiliated to Fudan University, Shanghai, 201508, PR China.
2: Neurosurgery, Fuzhou General Hospital, Fuzhou 350025, PR China.
3: Institutes of Biomedical Sciences, Fudan University, Shanghai, 200032, PR China.

Articles cited by this

Global, in vivo, and site-specific phosphorylation dynamics in signaling networks. Cell (2006) 20.92

HIV-1 cell to cell transfer across an Env-induced, actin-dependent synapse. J Exp Med (2004) 5.08

Programmed cell death in peripheral lymphocytes from HIV-infected persons: increased susceptibility to apoptosis of CD4 and CD8 T cells correlates with lymphocyte activation and with disease progression. J Immunol (1996) 3.05

Requirement for coronin 1 in T lymphocyte trafficking and cellular homeostasis. Science (2006) 2.85

Vinculin activation by talin through helical bundle conversion. Nature (2003) 2.26

Both long-term HIV infection and highly active antiretroviral therapy are independent risk factors for early carotid atherosclerosis. Atherosclerosis (2007) 2.16

Prevalence of adverse events associated with potent antiretroviral treatment: Swiss HIV Cohort Study. Lancet (2001) 2.01

Patterns and correlates of discontinuation of the initial HAART regimen in an urban outpatient cohort. J Acquir Immune Defic Syndr (2003) 1.83

G Protein betagamma subunits stimulate p114RhoGEF, a guanine nucleotide exchange factor for RhoA and Rac1: regulation of cell shape and reactive oxygen species production. Circ Res (2003) 1.79

Filamin-A regulates actin-dependent clustering of HIV receptors. Nat Cell Biol (2007) 1.71

Apoptotic cells overexpress vinculin and induce vinculin-specific cytotoxic T-cell cross-priming. Nat Med (2001) 1.66

Structural basis for amplifying vinculin activation by talin. J Biol Chem (2004) 1.48

Proteomic studies reveal coordinated changes in T-cell expression patterns upon infection with human immunodeficiency virus type 1. J Virol (2008) 1.40

Human immunodeficiency virus type 1-induced macrophage gene expression includes the p21 gene, a target for viral regulation. J Virol (2005) 1.37

HIV-1-specific T cell precursors with high proliferative capacity correlate with low viremia and high CD4 counts in untreated individuals. J Immunol (2008) 1.19

Vinculin binding in its closed conformation by a helix addition mechanism. EMBO J (2007) 1.18

Viral and host cofactors facilitate HIV-1 replication in macrophages. J Leukoc Biol (2003) 1.17

Proteomic analyses associate cystatin B with restricted HIV-1 replication in placental macrophages. Placenta (2008) 1.17

CSF proteomic fingerprints for HIV-associated cognitive impairment. J Neuroimmunol (2007) 1.16

Expression profiles and function of Toll-like receptors 2 and 4 in peripheral blood mononuclear cells of chronic hepatitis B patients. Clin Immunol (2008) 1.14

HIV replication enhances production of free fatty acids, low density lipoproteins and many key proteins involved in lipid metabolism: a proteomics study. PLoS One (2008) 1.14

Biomarkers of HIV-1 associated dementia: proteomic investigation of sera. Proteome Sci (2009) 1.06

Two-dimensional electrophoresis with immobilized pH gradients of leaf proteins from barley (Hordeum vulgare): method, reproducibility and genetic aspects. Electrophoresis (1988) 1.06

The use of proteomics to study infectious diseases. Infect Disord Drug Targets (2008) 1.04

Functional gene transfer of HIV DNA by an HIV receptor-independent mechanism. J Immunol (1999) 1.01

Proteomic modeling for HIV-1 infected microglia-astrocyte crosstalk. PLoS One (2008) 0.99

HIV-1 Nef triggers Vav-mediated signaling pathway leading to functional and morphological differentiation of dendritic cells. FASEB J (2003) 0.98

HIV infection changes glomerular podocyte cytoskeletal composition and results in distinct cellular mechanical properties. Am J Physiol Renal Physiol (2006) 0.97

Diminished matrix metalloproteinase 9 secretion in human immunodeficiency virus-infected mononuclear phagocytes: modulation of innate immunity and implications for neurological disease. J Neuroimmunol (2004) 0.95

Enhanced IL-10 production in response to hepatitis C virus proteins by peripheral blood mononuclear cells from human immunodeficiency virus-monoinfected individuals. BMC Immunol (2008) 0.93

HIV-1-infected astrocytes and the microglial proteome. J Neuroimmune Pharmacol (2008) 0.92

Serum proteome of leprosy patients undergoing erythema nodosum leprosum reaction: regulation of expression of the isoforms of haptoglobin. J Proteome Res (2007) 0.92

Phenotypic characteristics and tendency to apoptosis of peripheral blood mononuclear cells from HIV+ long term non progressors. Cell Death Differ (1997) 0.91

Cerebrospinal fluid proteomics reveals potential pathogenic changes in the brains of SIV-infected monkeys. J Proteome Res (2009) 0.90

Proteomic analysis of mouse liver plasma membrane: use of differential extraction to enrich hydrophobic membrane proteins. Proteomics (2005) 0.90

Human liver thermolabile phenol sulfotransferase: cDNA cloning, expression and characterization. Biochem Biophys Res Commun (1994) 0.90

Extended analysis of AL-amyloid protein from abdominal wall subcutaneous fat biopsy: kappa IV immunoglobulin light chain. Biochem Biophys Res Commun (1998) 0.89

HIV-1 DNA in peripheral blood mononuclear cells is strongly associated with HIV-1 disease progression in recently infected West African adults. J Acquir Immune Defic Syndr (2008) 0.89

Mitochondrial membrane potential and apoptosis of blood mononuclear cells in untreated HIV-1 infected patients. HIV Med (2009) 0.88

AZT: an old drug with new perspectives. Curr Clin Pharmacol (2008) 0.88

Proteomics/genomics and signaling in lymphocytes. Curr Opin Immunol (2004) 0.86

Organization of focal adhesion plaques is disrupted by action of the HIV-1 protease. Cell Biol Int (2002) 0.86

Immunoaffinity purification of plasma membrane with secondary antibody superparamagnetic beads for proteomic analysis. J Proteome Res (2007) 0.85

External quality assessment of automated hematology analyzer performance using fresh human blood samples in Shanghai. Lab Hematol (2003) 0.85

Endogenous HIV-1 Vpr-mediated apoptosis and proteome alteration of human T-cell leukemia virus-1 transformed C8166 cells. Apoptosis (2009) 0.82

Limited proteolysis of filamin is catalyzed by caspase-3 in U937 and Jurkat cells. J Biochem (2001) 0.82

Disruption of focal adhesions mediates detachment during neuronal apoptosis. Neuroreport (2001) 0.78

Direct role of plasma membrane-expressed gp120/41 in toxicity to human astrocytes induced by HIV-1-infected macrophages. AIDS (2000) 0.77

Identification of talin head domain as an immunodominant epitope of the antiplatelet antibody response in patients with HIV-1-associated thrombocytopenia. Blood (2004) 0.77

Proteome analysis of combined effects of androgen and estrogen on the mouse mammary gland. Proteomics (2006) 0.76